2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Interventions
Cyclophosphamide
3167
Cisplatin
3163
Carboplatin
2940
Paclitaxel
2675
Radiotherapy
2648
Gemcitabine
2548
pembrolizumab
2334
Docetaxel
2158
Bevacizumab
2129
Fluorouracil
1822
Capecitabine
1785
Oxaliplatin
1713
Dexamethasone
1591
Nivolumab
1517
Doxorubicin
1479
Rituximab
1455
Etoposide
1342
Magnetic Resonance Spectroscopy
1270
Irinotecan
1235
Leucovorin
1217
Cytarabine
1124
Pemetrexed
1064
Drug Therapy
1062
fludarabine
1052
Vincristine
958
Specimen Handling
940
Prednisone
927
Cetuximab
921
Lenalidomide
917
Trastuzumab
903
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
SR 48692
×
Clear all
NCT00290953
2008-12-23
SESAME
Sanofi
Phase 2/3
Completed
432 enrolled